Refine by
Heart Function Articles & Analysis
47 news found
It was another first for EchoPixel when its Holographic Therapy Guidance (HTG) was used in a congenital heart surgery at Cincinnati Children’s Hospital Medical Center. ...
Bodyport’s focus on the patient has driven them to create an incredibly simple solution for patients with congestive heart failure. The Bodyport solution will reduce common monitoring complexities for patients while advancing how clinicians manage their patients,” Pursley said. ...
Cloud Hospital with the first team to remove a heart tumor without invasive open heart surgery using the novel AlphaVac catheter. ...
This innovative solution enables people with fluid management conditions, such as heart failure and kidney disease, to noninvasively assess measures of heart function and fluid status in the same step they take to measure their weight. ...
SQuEEZ is based on the ability in high resolution cardiac CT scans to track points on the endocardium as they move during the contraction of the heart to allow quantitative assessment of regional myocardial heart wall motion. The analysis of four dimensional SQuEEZ parameters has the potential to improve the ability to quantify accurately the regional myocardial ...
Bodyport, a medtech company based in San Francisco, developed the Bodyport Cardiac Scale, a set of weighing scales that can non-invasively assess fluid status and heart function. The scales can detect these signals through the feet when a patient steps onto the device. ...
DSR (Direct Sodium Removal) heart failure drug development: Completed enrollment in SAHARA I[i] with first-generation DSR product (“DSR 1.0”) – extending study with second-generation DSR product (“DSR 2.0”) to support US IND[ii] filing by year end Proof-of-concept delivered in diuretic-resistant heart failure patients with ...
– July 12, 2022 – Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today announced that the U.S. ...
Lipman’s appointment comes as Bodyport prepares for commercialization of its proprietary Bodyport Cardiac Scale™, an innovative technology that remotely and noninvasively assesses heart function and fluid status in people living with fluid management conditions. ...
Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. Barostim works by stimulating baroreceptors - natural sensors in the body that tell the nervous system how to regulate heart, kidney and vascular function. These effects reduce ...
ByCVRx
In most cases, the coenzyme provides a transfer site for the functional enzyme, and it usually acts as an intermediate carrier for electrons, specific atoms, or functional groups, allowing the reaction to take place. ...
“The published results from our clinical trials to date [3], [4]. [5],[6], [7] have met our high expectations in showing the therapy’s ability to address the loss of heart function in ischemic heart failure. We look forward to completing our Phase III trial and engaging with the FDA as we move closer to the prospect of benefiting ...
The presentations include a spotlight on the company’s first US case treating a patient with heart failure (HF) and worsening renal function (WRF), a condition known as cardiorenal syndrome (CRS). ...
Kosmos’ AI-driven system enables automated assessment of systolic heart function at bedside and is the only “hybrid” device in its category to provide diagnostic-quality scans while also meeting HIPAA requirements for data collection, storage, and transmission. Kosmos is rapidly emerging as a tool of choice for cardiologists and critical care ...
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the launch of the U.S. pivotal study The EMPOWER Trial. The EMPOWER Trial is evaluating the Carillon Mitral Contour System® for the treatment of heart failure patients with ...
RVOT reconstruction is a procedure needed to correct certain congenital heart defects. Following implantation, Xeltis’ synthetic restorative pulmonary heart valves evolve into fully functioning, natural heart valves through colonization by the patient’s own tissue. The implants’ porous micro-structure enables ...
Studies have shown that the DynamX Bioadaptor improves vessel function in several ways.9 It enables the vessel to accommodate disease progression and achieve positive adaptive remodeling by increasing vessel area and maintaining lumen diameter, which preserves blood flow to the heart. DynamX restores vessel function and allows for normal vessel ...
Both of the published meta-analyses were conducted from three prospective, core lab reviewed, CEC/DSMB adjudicated and third-party monitored clinical studies which enrolled a total of 209 heart failure patients with reduced ejection fraction and functional mitral regurgitation (FMR). ...
Especially for older patients and those with chronic diseases, information such as blood pressure, blood sugar, weight, heart rate, oxygen level, and lung function can be crucial for prescribing the right treatments and avoiding costly acute events. ...
The benefits of restored vessel function may provide greater benefit in patients with complex disease. ...